Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 6313625, 14 pages
https://doi.org/10.1155/2017/6313625
Review Article

Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms

Department of Cardiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China

Correspondence should be addressed to Guo-Qing Zheng; moc.uhos@gnehz_qg and Yan Wang; moc.anis@anihczwyw

Received 17 July 2017; Revised 1 November 2017; Accepted 12 November 2017; Published 21 December 2017

Academic Editor: Sharad S. Singhal

Copyright © 2017 Qun Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. S. Weintraub, S. R. Daniels, L. E. Burke et al., “Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association,” Circulation, vol. 124, no. 8, pp. 967–990, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Ribas, C. Garcia-Garcia, O. Merono et al., “Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion,” BMC Cardiovascular Disorders, vol. 17, no. 1, p. 54, 2017. View at Publisher · View at Google Scholar
  4. G. Heusch and B. J. Gersh, “The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge,” European Heart Journal, vol. 38, no. 11, pp. 774–784, 2017. View at Publisher · View at Google Scholar
  5. M. Seewald, J. J. Coles, D. C. Sigg, and P. A. Iaizzo, “Featured article: pharmacological postconditioning with delta opioid attenuates myocardial reperfusion injury in isolated porcine hearts,” Experimental Biology and Medicine, vol. 249, no. 9, pp. 986–995, 2017. View at Publisher · View at Google Scholar
  6. T. Schonberger, T. Jurgens, J. Muller et al., “Pivotal role of phospholipase D1 in tumor necrosis factor-α-mediated inflammation and scar formation after myocardial ischemia and reperfusion in mice,” The American Journal of Pathology, vol. 184, no. 9, pp. 2450–2464, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Guo, S. Zhao, Y. X. Du, Q. J. Xing, B. L. Chen, and C. Q. Yu, “Effects of ginsenoside Rg1-loaded alginate-chitosan microspheres on human bone marrow stromal cells,” Bioscience Reports, vol. 37, no. 3, 2017. View at Publisher · View at Google Scholar
  8. S. A. Palaniyandi, J. W. Suh, and S. H. Yang, “Preparation of ginseng extract with enhanced levels of ginsenosides Rg1 and Rb1 using high hydrostatic pressure and polysaccharide hydrolases,” Pharmacogn Magazine, vol. 13, no. 1, pp. 142–147, 2017. View at Publisher · View at Google Scholar
  9. K. W. Leung, L. W. Cheung, Y. L. Pon et al., “Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor,” British Journal of Pharmacology, vol. 152, no. 2, pp. 207–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Lu, Q. Z. Yao, and C. Y. Chen, “Ginseng compounds: an update on their molecular mechanisms and medical applications,” Current Vascular Pharmacology, vol. 7, no. 3, pp. 293–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. H. Kwok, L. S. Chan, P. Y. Poon, P. Y. K. Yue, and R. N. S. Wong, “Ginsenoside-Rg1 induces angiogenesis by the inverse regulation of MET tyrosine kinase receptor expression through miR-23a,” Toxicology and Applied Pharmacology, vol. 287, no. 3, pp. 276–283, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Li, J. Xu, X. Wang, and G. Yuan, “Protective effect of ginsenoside Rg1 on lidocaine-induced apoptosis,” Molecular medicine Reports, no. 2, pp. 395–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Y. Li, W. Deng, X. Q. Liao, J. Deng, Y. K. Zhang, and D. X. Wang, “The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension,” European Journal of Medical Research, vol. 18, no. 1, pp. 16–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. L. Kong, Z. Q. Li, and L. Yuan, “Ginsenosides Rb1 inhibits the hypertrophy of cardiomyocytes via nitric oxide synthase/nitric oxide system,” Guangdong Medical Journal, vol. 33, no. 2, pp. 167–169, 2011. View at Google Scholar
  15. J. Van, M. Luijk, C. Leenaars et al., “Towards evidence-based translational research: the pros and cons of conducting systematic reviews of animal studies,” ALTEX, vol. 30, no. 2, pp. 256-257, 2013. View at Publisher · View at Google Scholar
  16. M. R. Macleod, T. O’Collins, D. W. Howells, and G. A. Donnan, “Pooling of animal experimental data reveals influence of study design and publication bias,” Stroke, vol. 35, no. 5, pp. 1203–1208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Yu, K. J. Zhang, J. Z. Zhu et al., “Salvianolic acid exerts cardioprotection through promoting angiogenesis in animal models of acute myocardial infarction: preclinical evidence,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8192383, 11 pages, 2017. View at Publisher · View at Google Scholar
  18. L. Zhang and Z. Y. Xia, “Protective effect of ginsenoside Rbl pre-conditioninlg on myocardium against ischemia-reperfusion injury in diabetic rats,” Chinese Journal of Medicinal Guide, vol. 12, no. 3, pp. 446–449, 2010. View at Google Scholar
  19. Y. Wang and Y. Y. Zhang, “Protective effect and mechanisms of ginsenoside Rb1 on myocardial ischemia-reperfusion injury via p38MAPK signaling pathways,” World Latest Medicine Information, vol. 16, no. 101, pp. 80–90, 2016. View at Google Scholar
  20. H. X. Chen, “Protective effect of ginsenoside Rb1 on myocardial ischemia-reperfusion injury in rats,” Journal of Hubei University of Science and Technology, vol. 26, no. 6, pp. 465–467, 2012. View at Google Scholar
  21. X. Leng, L. D. Zhang, L. Q. Jia et al., “Effect of ginsenoside Rb1 on isoproterenol-induced acute myocardial ischemia in rats and its mechanism of action,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 21, no. 24, pp. 104–108, 2015. View at Google Scholar
  22. C. E. Liu, S. X. Wu, and G. Ye, “Mechanism of ginsenoside Rb1 against myocardial apoptosis during ischemia-reperfusion injury in diabetic rats,” Journal of Emergency in Traditional Chinese Medicine, vol. 21, no. 7, pp. 1080-1081, 2012. View at Google Scholar
  23. F. Y. Liu, Effects of Ginsenoside Rb1 on Blood Vessel Regeneration and Heart Function in Rats with Acute Myocardial Infarction, Huazhong University of Science and Technology, China, 2008. View at Publisher · View at Google Scholar
  24. P. Li, Effects of Ginsenoside Rb1 on Ventricular Remodeling in Rats with Acute Myocardial Infarction, Huazhong University of Science and Technology, China, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. S. Zeng, Z. X. Liu, and X. C. Liu, “Effect of ginsenoside-Rb1 and Re against cardiomyocyte apoptosis and expression of the related gene proteins in the experimental cardiac ischemia-reperfusion in rats,” Chinese Journal of Physical Medicine and Rehabilitation, vol. 25, no. 7, pp. 402–405, 2003. View at Google Scholar
  26. Z. Wang, M. Li, W. K. Wu, H. M. Tan, and D. F. Geng, “Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction,” Cardiovascular Drugs and Therapy, vol. 22, no. 6, pp. 443–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wu, Z. Y. Xia, J. Dou et al., “Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats,” Molecular Biology Reports, vol. 38, no. 7, pp. 4327–4335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Schmucker, A. Bluemle, M. Briel et al., “A protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analyses,” Systematic Reviews, vol. 2, p. 24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Blankstein, W. Ahmed, F. Bamberg et al., “Comparison of exercise treadmill testing with cardiac computed tomography angiography among patients presenting to the emergency room with chest pain: the rule out myocardial infarction using computer-assisted tomography (ROMICAT) study,” Circulation: Cardiovascular Imaging, vol. 5, no. 2, pp. 233–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Menazza, J. Sun, S. Appachi et al., “Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice,” Journal of Molecular and Cellular Cardiology, vol. 107, pp. 41–51, 2017. View at Publisher · View at Google Scholar
  31. P. A. Curbel, C. S. MacCord, R. D. Anderson et al., “A canine model of acute coronary artery thrombosis for the evaluation of reperfusion strategies,” Cardiology, vol. 84, no. 1, pp. 1–8, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. M. V. V. Kolk, D. Meyberg, T. Deuse et al., “LAD-ligation: a murine model of myocardial infarction,” Journal of Visualized Experiments, vol. 14, no. 32, pp. 1–3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Arteaga, F. G. Ferro, S. O. Villanueva et al., “99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats,” International Journal of Pharmaceutics, vol. 233, no. 1, pp. 29–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Y. Jin, “Establishment an of animal model of myocardial infarction,” Chinese Journal of CT and MRI, vol. 6, no. 4, pp. 73–75, 2008. View at Google Scholar
  35. J. Chu, M. Q. Xu, H. He, K. Chen, S. Ye, and Z. Zhai, “Experimental study of acute myocardial infarction model in dogs,” Anhui Medical Journal, vol. 23, no. 2, pp. 6-7, 2002. View at Google Scholar
  36. P. E. Thorpe, W. J. Hunter, X. X. Zhan, P. S. Dovgan, and D. K. Agrawal, “A non-injury diet-induced model of atherosclerosis for cardiovascular interventional research,” Angiology, vol. 47, no. 9, pp. 849–858, 1996. View at Publisher · View at Google Scholar
  37. S. T. Rashid, H. J. Salacinski, G. Hamilton, and A. M. Seifalian, “The use of animal models in developing the discipline of cardiovascular tissue engineering: a review,” Biomaterials, vol. 25, no. 9, pp. 1627–1637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. H. S. Baldwin, “Advances in understanding the molecular regulation of cardiac development,” Current Opinion in Pediatrics, vol. 11, no. 5, pp. 413–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. J. R. Turk and M. H. Laughlin, “Physical activity and atherosclerosis: which animal model?” Canadian Journal of Applied Physiology, vol. 29, no. 5, pp. 657–683, 2004. View at Publisher · View at Google Scholar
  40. M. H. Moghadasian, J. J. Frohlich, and B. M. McManus, “Advances in experimental dyslipidemia and atherosclerosis,” Laboratory Investigation, vol. 81, no. 9, pp. 1173–1183, 2004. View at Publisher · View at Google Scholar
  41. S. Wolfensohn and M. Lloyd, “Handbook of Laboratory Animal Management and Welfare,” Canadian Veterinary Journal, vol. 41, no. 3, p. 3, 2000. View at Google Scholar
  42. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1121–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Downey and M. V. Cohen, “Why do we still not have cardioprotective drugs?” Circulation Journal, vol. 73, no. 7, pp. 1171–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. D. J. Hausenloy, H. E. Botker, G. Condorelli et al., “Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology,” Cardiovascular Research, vol. 98, no. 1, pp. 7–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Xu, “Research on main mechanisms of myocardial ischemia reperfusion injury and related drug therapy,” Practical Pharmacy And Clinical Remedies, vol. 17, no. 8, pp. 1052–1055, 2014. View at Google Scholar
  46. Y. Wu and L. He, “Advances in research on mechanisms of myocardial ischemia-reperfusion injury and related therapeutic drugs,” Progress in Pharmaceutical Sciences, vol. 34, no. 7, pp. 305–312, 2010. View at Google Scholar
  47. S. Bodiga, W. Wang, and G. Y. Oudit, “Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies,” Journal of Molecular Medicine, vol. 89, no. 4, pp. 317–320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. D. G. Hackam and D. A. Redelmeier, “Translation of research evidence from animals to humans,” JAMA, vol. 296, no. 14, pp. 1731-1732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Moher, M. Avey, G. Antes, and D. G. Altman, “The National Institutes of Health and guidance for reporting preclinical research,” BMC Medicine, vol. 13, no. 34, pp. 1-2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research,” PLoS Biology, vol. 1, no. 2, pp. 94–99, 2010. View at Publisher · View at Google Scholar
  51. D. Baker, K. Lidster, A. Sottomayor, and S. Amor, “Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies,” PLoS Biology, vol. 12, no. 1, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. D. G. Hackam, “Translating animal research into clinical benefit,” British Medical Journal, vol. 334, no. 7586, pp. 163-164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. G. A. Rongen and K. E. Wever, “Cardiovascular pharmacotherapy: innovation stuck in translation,” European Journal of Pharmacology, vol. 15, no. 759, pp. 200–204, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Glasziou, J. P. Vandenbroucke, and I. Chalmers, “Assessing the quality of research,” British Medical Journal, vol. 3, no. 328, pp. 39–41, 2004. View at Publisher · View at Google Scholar